Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Traveler's Diarrhea |
Dose: by mouth – 200 mg Frequency: every 8 hours Duration: 3 days |
|
Indication: Hepatic Encephalopathy Condition: Maintenance of remission |
Dose: by mouth – 550 mg Frequency: every 12 hours |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Traveler's Diarrhea Age: less than 12 years |
Dose: Not established Note: Safety and efficacy not established |
|
Indication: Traveler's Diarrhea Age: greater than 12 years |
Dose: PO – 200 mg Frequency: every 8 hours Duration: for 3 days Note: by mouth (oral), with or without food |
Administration
- Can take with or without food
- Complete full prescribed course
Side Effect
- Headache (10%)
- Rectal tenesmus (7%)
- Abdominal pain (7%)
- Defecation urgency (6%)
- Nausea (5%)
- Constipation (4%)
- Pyrexia (3%)
- Vomiting (2%)
- Hypersensitivity reactions (including allergic dermatitis)
- Pruritus
- Rash
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Midazolam
|
Did not significantly affect pharmacokinetics
|
|
Ethinyl estradiol, Norgestimate
|
No effect on presystemic metabolism
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Hypersensitivity
|
Risk of allergic reactions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.